Based on the expression pattern of hormone receptors (HR) and human epidermal growth factor receptor 2 (HER2) on cancer cells, breast cancer generally falls into four subtypes as luminal A, luminal B, HER2+ and triple-negative [28, 29]. This evidence concerns the gene ERBB2 and breast carcinoma.